212 related articles for article (PubMed ID: 10374691)
1. Semi-quantitative procedure for telomeric repeat amplification protocol (TRAP) assay in colorectal carcinomas.
Fujita M; Tomita S; Fukui H; Ueda Y; Fujimori T
J Exp Clin Cancer Res; 1999 Mar; 18(1):119-24. PubMed ID: 10374691
[TBL] [Abstract][Full Text] [Related]
2. Change in telomerase activity during human colorectal carcinogenesis.
Yoshida R; Kiyozuka Y; Ichiyoshi H; Senzaki H; Takada H; Hioki K; Tsubura A
Anticancer Res; 1999; 19(3B):2167-72. PubMed ID: 10472326
[TBL] [Abstract][Full Text] [Related]
3. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in different clinical staging of colorectal adenocarcinoma.
Lukman K; Maskoen AM; Achmad TH; Hanafi B; Karnadihardja W
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():491-7. PubMed ID: 10895200
[TBL] [Abstract][Full Text] [Related]
6. Telomerase activity and p53 gene mutation in familial polyposis coli.
Ikeguchi M; Makino M; Kaibara N
Anticancer Res; 2000; 20(5C):3833-7. PubMed ID: 11268463
[TBL] [Abstract][Full Text] [Related]
7. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer.
Tatsumoto N; Hiyama E; Murakami Y; Imamura Y; Shay JW; Matsuura Y; Yokoyama T
Clin Cancer Res; 2000 Jul; 6(7):2696-701. PubMed ID: 10914712
[TBL] [Abstract][Full Text] [Related]
8. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in stage II colorectal carcinoma.
Kawanishi-Tabata R; Lopez F; Fratantonio S; Kim N; Goldblum J; Tubbs R; Elson P; Lavery I; Bukowski RM; Ganapathi R; Ganapathi MK
Cancer; 2002 Nov; 95(9):1834-9. PubMed ID: 12404275
[TBL] [Abstract][Full Text] [Related]
10. [Study of telomerase activity in colorectal carcinomas].
Zhao D; Zhang W; Jin S
Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):199-201. PubMed ID: 10921007
[TBL] [Abstract][Full Text] [Related]
11. [Telomerase activity in human gastric and colorectal cancer].
Chen W; Zhang Q; Wan D
Zhonghua Zhong Liu Za Zhi; 1998 Jul; 20(4):261-3. PubMed ID: 10920978
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma.
Engelhardt M; Albanell J; Drullinsky P; Han W; Guillem J; Scher HI; Reuter V; Moore MA
Clin Cancer Res; 1997 Oct; 3(10):1849-57. PubMed ID: 9815573
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of human telomerase reverse transcriptase in patients with colon cancer].
Li LR; Wan DS; Pan ZZ; Hardingham J; Rieger N; Hewett P; Zhou ZW; Chen G
Ai Zheng; 2004 Nov; 23(11 Suppl):1502-7. PubMed ID: 15566667
[TBL] [Abstract][Full Text] [Related]
14. [Telomerase activity in colorectal cancer--a semi-quantitative procedure].
Ohki S; Satoh H; Watanabe F; Andoh Y; Nomizu T; Yoshida T; Tsuchiya A; Abe R; Yamaki Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():469-74. PubMed ID: 9589055
[TBL] [Abstract][Full Text] [Related]
15. [Telomerase activity in colorectal carcinoma and its relationship to clinicopathological findings].
Iida A; Yamaguchi A; Ohtaki N; Goi T; Hirose K; Nakagawara G
Nihon Rinsho; 1998 May; 56(5):1214-7. PubMed ID: 9613125
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas.
Kumaki F; Kawai T; Hiroi S; Shinomiya N; Ozeki Y; Ferrans VJ; Torikata C
Hum Pathol; 2001 Feb; 32(2):188-95. PubMed ID: 11230706
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of hTERT mRNA expression in colorectal cancer.
Niiyama H; Mizumoto K; Sato N; Nagai E; Mibu R; Fukui T; Kinoshita M; Tanaka M
Am J Gastroenterol; 2001 Jun; 96(6):1895-900. PubMed ID: 11419845
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of human telomerase reverse transcriptase in human colorectal carcinomas by in situ hybridization.
Kammori M; Kanauchi H; Nakamura K; Kawahara M; Weber TK; Mafune K; Kaminishi M; Takubo K
Int J Oncol; 2002 Jan; 20(1):15-21. PubMed ID: 11743637
[TBL] [Abstract][Full Text] [Related]
20. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
